Sclerostin: A new mediator of crosstalk between the skeletal and immune systems

Journal of Bone and Mineral Research

Volumn 27, Issue 7, 2012, Pages 1448-1450

  Horowitz, Mark C ^a   Fretz, Jackie A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SCLEROSTIN;

B LYMPHOCYTE DIFFERENTIATION; BONE CELL; HUMAN; IMMUNE SYSTEM; MEDIATOR; NONHUMAN; NOTE; OSTEOBLAST; OSTEOCYTE; PROTEIN ANALYSIS; PROTEIN FUNCTION; SKELETON;

ANIMALS; BONE AND BONES; FEMALE; GLYCOPROTEINS; IMMUNE SYSTEM; MALE;

EID: 84862496395     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1672     Document Type: Note

References (21)

1. Cain CJ, Rueda R, McLelland B, Collette NM, Loots GG, Manilay JO. Absence of sclerostin adversely affects B cell survival. J Bone Miner Res. 2012;27:1451-1461.
2. Horowitz MC, Xi Y, Pflugh DL, Hesslein DGT, Schatz DG, Lorenzo JA, Bothwell ALM. Pax5 deficient mice exhibit early onset osteoporosis with increased osteoclast progenitors. J Immunol. 2004;173:6583-91. (Pubitemid 39541041)
3. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 1999;397:315-23.
4. Ghia P, ten Boekel E, Rolink AG, Melchers F. B-cell development: a comparison between mouse and man. Immunol Today. 1998;19:480-5. (Pubitemid 28451891)
5. Hesslein DG, Schatz DG. Factors and forces controlling V(D)J recombination. Adv Immunol. 2001;78:169-232. (Pubitemid 32566020)
6. Hardy RR, Hayakawa K. B cell development pathways. Annu Rev Immunol. 2001;19:595-621. (Pubitemid 32368047)
7. Li YS, Wasserman R, Hayakawa K, Hardy RR. Identification of the earliest B lineage stage in mouse bone marrow. Immunity. 1996;5:527-35. (Pubitemid 27062063)
8. Rolink A, Haasner D, Melchers F, Andersson J. The surrogate light chain in mouse B-cell development. Int Rev Immunol. 1996;13(4):341-56. (Pubitemid 27101209)
9. Nemazee D. Receptor editing in B cells. Adv Immunol. 2000;74:89-126.
10. Li X, Ominsky MS, Niu QT, Sun N, Daugherty B, D'Agostin D, Kurahara C, Gao Y, Cao J, Gong J, Asuncion F, Barrero M, Warmington K, Dwyer D, Stolina M, Morony S, Sarosi I, Kostenuik PJ, Lacey DL, Simonet WS, Ke HZ, Paszty C. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res. 2008;23(6):860-9. (Pubitemid 351768804)
11. Scott EW, Simon MC, Anastasi J, Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science. 1994;265:1573-7.
12. Tondravi MM, McKercher SR, Anderson K, Erdmann JM, Quiroz M, Maki R, Teitelbaum SL. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature. 1997;386:81-4. (Pubitemid 27130924)
13. Scott EW, Fisher RC, Olson MC, Kehrli EW, Simon MC, Singh H. PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors. Immunity. 1997;6:427-47.
14. DeKoter RP, Singh H. Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science. 2000;288:1439-41.
15. Lin H, Grosschedl R. Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature. 1995;376(6537):263-7.
16. Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, Yoshida N, Kikutani H, Kishimoto T. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokines PBSF/SDF-1. Nature. 1996;382:635-8. (Pubitemid 26268957)
17. Ma Q, Jones D, Springer TA. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity. 1999;10:463-71. (Pubitemid 29205482)
18. Nie Y, Waite J, Brewer F, Sunshine MJ, Littman DR, Zou YR. The role of CXCR4 in maintaining peripheral B cell compartments and humoral immunity. J Exp Med. 2004;200(9):1145-56. (Pubitemid 39507054)
19. Visnjic D, Kalajzic Z, Rowe DW, Katavic V, Lorenzo J, Aquila HL. Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood. 2004;103:3258-64. (Pubitemid 38525648)
20. Mansour A, Anginot A, Mancini SJC, Schiff C, Carle GF, Wakkach A, Blin-Wakkach C. Osteoclast activity modulates B-cell development in the bone marrow. Cell Res. 2011;21:1102-15.
21. Padhi D, Jang G, Stouch B, Fang L, Posvar E. Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody. J Bone Miner Res. 2010;26(1):19-26.